Breaking News

Quintiles Acquires Outcome Sciences

Adds Late Phase Offerings

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Quintiles has acquired Outcome Sciences, Inc., a privately held outcomes research firm headquartered in Cambridge, MA. The acquisition adds late phase research, offering global reach, dedicated resources and specialization. Outcome is a provider of observational research services encompassing registries, post-approval research and quality improvement initiatives across biopharmaceutical, medical device, government and providers. Outcome’s programs across more than 40 therapeutic areas include t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters